DiaMedica Therapeutics Inc.(DMAC)

盘后5.770.000.00%16:05 EDT

5.77+0.10+1.76%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
暂无内容
公司概况
公司名称
DiaMedica Therapeutics Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.diamedica.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Diamedica Therapeutics Inc.最初是根据《公司法》（马尼托巴省）于2000年1月21日通过公司章程成立的。2019年5月31日，从根据CBCA成立的公司继续存在到根据BCBCA成立的不列颠哥伦比亚省。该公司是一家临床阶段的生物制药公司，致力于改善患有严重疾病的人的生活。Diamedica疗法的主要候选药物DM199是第一个在患者中研究的具有药物活性的重组（合成）形式的人体组织激肽释放酶-1（KLK1）蛋白。
- 03-06
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 02-24
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-11-13
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-11-13
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-08-07
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-08-07
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-07-16
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-07-08
  超过5%披露
  Form SC 13G - Statement of Beneficial Ownership by Certain Investors
  Form SC 13G - Statement of Beneficial Ownership by Certain Investors
- 2024-07-02
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2024-06-26
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-06-26
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-05-24
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 2024-05-23
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-05-08
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-05-08
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report